|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 215/56 | (2006.01) |
| A61K 31/445 | (2006.01) |
| (11) | Number of the document | 3219705 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17154944.7 |
| Date of filing the European patent application | 2006-12-28 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation | 2020-04-27 |
| (30) | Number | Date | Country code |
| 754381 P | 2005-12-28 | US |
| (72) |
HURTER, Patricia, US
GONG, Yuchuan, US
YOUNG, Christopher R., US
CONNELLY, Patrick, US
ROWE, William, US
COSTACHE, Adriana, US
KRAWIEC, Mariusz, US
FENG, Yushi, US
TRUDEAU, Martin, CA
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-[2,4-bis(1,1-dimetilen)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido amorfinės formos farmacinės kompozicijos |
| PHARMACEUTICAL COMPOSITIONS OF THE AMORPHOUS FORM OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 19 | 347.00 EUR |
| 2025-12-28 |